Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Arno therapeutics Inc (ARNI)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 48,278,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4 - $0.4
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Arno Therapeutics is an early stage enterprise engaged in developing products for the treatment of cancer and other diseases. As of Dec 31 2015, Co.'s product development pipeline consisted of: Onapristone, which is an anti-progestin hormone blocker that has been shown to have considerable anti-tumor activity in patients with breast cancer; AR-12, which is an orally available cancer treatment that has been shown in clinical studies to inhibit multiple different kinase targets; and AR-42, which is an oral cancer therapy and a deacetylase inhibitor of both histone and non-histone proteins, which has demonstrated activity in solid tumors and hematological malignancies.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 12
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Zucker Jonathan J   –       –       •   2016-12-30 3 IO $0.00 $0 D/D 0 4,285,111     -
   Sussman S Donald See Footnote 1   •       •      –    2016-12-30 4 S $0.00 $0 D/D (4,285,111) 714,285     -
   Tanen David M Secretary   •       •      –    2016-10-03 4 B $0.00 $0 D/D 142,857 314,569 2.73     -
   Sussman S Donald See Footnote 1   –       –       •   2016-08-15 4 B $0.00 $0 D/D 714,285 714,285 2.37     -
   Kariv Tomer Director   –       •      –    2016-08-15 4 B $0.00 $0 I/I 714,285 496,068 2.02     -
   Belldegrun Arie Director   –       •      –    2016-08-15 4 B $0.00 $0 I/I 714,285 2,262,838 2.02     -
   Tanen David M Secretary   •       •      –    2016-01-12 4 B $0.35 $126,705 I/I 362,015 362,015 2.66     -
   Zukiwski Alexander A VP & Chief Medical Officer   •       •      –    2016-01-12 4 B $0.35 $50,682 D/D 144,806 261,832 2.81     -
   Belldegrun Arie Director   –       •      –    2016-01-12 4 B $0.35 $756,821 I/I 2,162,347 858,094 2.1     -
   Kariv Tomer Director   –       •      –    2016-01-12 4 B $0.35 $506,822 I/I 1,448,062 393,968 2.1     -
   Moorin Jay Director   –       •      –    2016-01-12 3 IO $0.00 $0 D/D 0 642,858     -
   Ruchefsky Steven B Director   –       •      –    2016-01-12 4 B $0.35 $1,006,822 I/I 2,876,633 4,472,905 2.1     -

  12 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed